[STUDY OF CHEMOKINE RECEPTOR CCR2 GENE POLYMORPHISM IN PATIENTS WITH ASTHMA AND THEIR RELATIVES].

Q4 Medicine Tuberculosis and Lung Diseases Pub Date : 2010-01-01
{"title":"[STUDY OF CHEMOKINE RECEPTOR CCR2 GENE POLYMORPHISM IN PATIENTS WITH ASTHMA AND THEIR RELATIVES].","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The goal of this investigation was to study the frequency of genotypes and alleles of CCR2 gene polymorphism V64I in patients with asthma and their relatives. The families of 70 probands diagnosed as having asthma and their 165 first-, second-, and third-degree relatives (a study group) were examined. The mean age of the probands was 45.65 ± 16.34 years; that of the relatives was 49.15 ± 15.23 years. The control group included 464 healthy individuals (mean age 32.7 ± 7.36). No statistically significant differences were found in the distribution of genotypes and alleles of the CCR2 gene between the probands, asthmatic patients, and controls. There were statistically significant differences in the distribution of allele frequencies between the groups of relatives with allergy and healthy relatives. The proportion of 641 allele carriers was significantly higher in the group of relatives with allergy than that of healthy relatives (p = 0.01). The odds ratio of identifying a 64I allele carrier in the group of relatives with allergy was 2.6 times higher than that in healthy relatives (95% CI, 1.3-5.4). It can be inferred that 64I allele carriage is a predisposing factor for allergy. The findings of CCR2 gene polymorphism are important to form a risk group, by taking into account the genotype of individuals by the CCR2 gene.</p>","PeriodicalId":37828,"journal":{"name":"Tuberculosis and Lung Diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberculosis and Lung Diseases","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The goal of this investigation was to study the frequency of genotypes and alleles of CCR2 gene polymorphism V64I in patients with asthma and their relatives. The families of 70 probands diagnosed as having asthma and their 165 first-, second-, and third-degree relatives (a study group) were examined. The mean age of the probands was 45.65 ± 16.34 years; that of the relatives was 49.15 ± 15.23 years. The control group included 464 healthy individuals (mean age 32.7 ± 7.36). No statistically significant differences were found in the distribution of genotypes and alleles of the CCR2 gene between the probands, asthmatic patients, and controls. There were statistically significant differences in the distribution of allele frequencies between the groups of relatives with allergy and healthy relatives. The proportion of 641 allele carriers was significantly higher in the group of relatives with allergy than that of healthy relatives (p = 0.01). The odds ratio of identifying a 64I allele carrier in the group of relatives with allergy was 2.6 times higher than that in healthy relatives (95% CI, 1.3-5.4). It can be inferred that 64I allele carriage is a predisposing factor for allergy. The findings of CCR2 gene polymorphism are important to form a risk group, by taking into account the genotype of individuals by the CCR2 gene.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
【哮喘患者及其亲属趋化因子受体ccr2基因多态性研究】。
本研究的目的是研究哮喘患者及其亲属CCR2基因多态性V64I基因型和等位基因的频率。70个被诊断患有哮喘的先证者的家庭和他们的165个一、二、三度亲属(一个研究组)被检查。先证者平均年龄45.65±16.34岁;亲属平均年龄为49.15±15.23岁。对照组健康者464例,平均年龄(32.7±7.36)岁。先证者、哮喘患者和对照组CCR2基因型和等位基因的分布无统计学差异。过敏症亲属与健康亲属等位基因频率分布差异有统计学意义。过敏亲属641等位基因携带者比例显著高于健康亲属(p = 0.01)。过敏亲属中64I等位基因携带者的比值比是健康亲属的2.6倍(95% CI, 1.3 ~ 5.4)。由此推断,携带64I等位基因是过敏的易感因素。考虑到CCR2基因对个体的基因型,CCR2基因多态性的发现对于形成风险组具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Tuberculosis and Lung Diseases
Tuberculosis and Lung Diseases Medicine-Pulmonary and Respiratory Medicine
CiteScore
1.20
自引率
0.00%
发文量
88
审稿时长
8 weeks
期刊介绍: The Journal is aimed for professional development of researchers, doctors, teachers of medical universities and training institutions. The Journal focuses on the presentation of results of research, case studies, issues of differential diagnostics and treatment in the phthisiologist’s practice, national programs on tuberculosis control in the Russian Federation, WHO strategies, discussion of prevention issues to stop transmission of TB/HIVco-infection, and extrapulmonary tuberculosis.
期刊最新文献
Treatment Results in Patients with Drug Resistant Tuberculosis (MDR, pre-XDR, XDR) and HIV Infection in Stavropol Region Impact of the COVID-19 Restrictive Measures on Tuberculosis Detection among Children and Adolescents Sarcoidosis Phenotyping: Analysis of Current Approaches (Review) Postponed Results of Lung Resections for Disseminated Fibrous Cavernous Tuberculosis Lung Imaging for Suspected Tuberculosis in the Pregnant (Review)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1